Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Glycyl-L-histidyl-L-lysine-Cu2+ (GHK-Cu) Attenuates CuSO4 or LPS induced-inflammation in Zebrafish larvae model
European journal of pharmacology, 2026;1023:178880
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Sports medicine (Auckland, N.Z.), 2026
The Laccase-like Property of GHK-Cu and Its Applications in Colorimetric Sensing of Phenolic Compounds
Biosensors, 2026;16(4)
Impact of incretin therapies on biochemical and imaging outcomes in metabolic dysfunction-associated steatotic liver disease
American journal of preventive cardiology, 2026;28:101623
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Frontiers in aging, 2026;7:1790247
Magnitude and Determinants of Weight Loss Response to GLP-1/GIP Receptor Agonists in India: A Real-World Time-to-Event Analysis
Indian journal of endocrinology and metabolism, 2026;30(2):129-134
Spontaneous Pneumomediastinum Associated with Semaglutide Therapy: A Case Report
Case reports in gastroenterology, 2026;20(1):149-156
PEGylated thymosin β4 is a thiol-site-specific prodrug treating myocardial infarction in vivo
Bioengineering & translational medicine, 2026;11(4):e70144
[Semaglutide and Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review]
Acta gastroenterologica Latinoamericana, 2026;56(1):59-70
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review
The Journal of sports medicine and physical fitness, 2026
GLP-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes
Chronic diseases and translational medicine, 2026;12(2):85-99
Lifetime cost-effectiveness of semaglutide for secondary prevention in atherosclerotic cardiovascular disease: A select-based simulation study
American journal of preventive cardiology, 2026;28:101543
From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management
International journal of molecular sciences, 2026;27(6)
Semaglutide in Metabolic Medicine: A Review on Clinical Applications and Emerging Therapeutics
Saudi medical journal, 2026;47(4):615-625
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats
Current neuropharmacology, 2026
Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics
Pharmaceuticals (Basel, Switzerland), 2026;19(3)
Attitudes Toward Injectable GLP-1 Drugs for Obesity Treatment: A Qualitative Interview Study With Healthcare Professionals
Obesity science & practice, 2026;12(2):e70130
Association between semaglutide 2.4 mg and risk of cardiovascular events in people with overweight or obesity without atherosclerotic cardiovascular disease in the real-world: The SCORE – primary prevention study
American journal of preventive cardiology, 2026;27:101521
Anti-Obesity Pharmacotherapy and Emerging Multimodal Interventions for Obstructive Sleep Apnea
Chronic diseases and translational medicine, 2026;12(2):100-112
Comparative Proteomic Analysis of the Secretome of Control and BRAF/MEK Inhibitor-Resistant Melanoma Cells
Journal of proteome research, 2026;25(4):2084-2097